Clinical trial
Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or…
NCT00077155 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00077155 |
|---|---|
| Title | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma |
| Official title | A Phase I Study Of Continuous Infusion EMD 121974 In Patients With Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma and 46 more |
| Intervention type | Drug |
| Interventions | cilengitide |
| Enrollment | 45 |
| Start date | Dec 1, 2003 |
| Primary completion | Jun 1, 2010 |
| First posted | Feb 11, 2004 |
| Last update posted | Jan 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: